WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
System and method for non-invasively monitoring hemodynamic parameters    

Get related patents on CD
United States Patent6280390   
Link to this pagehttp://www.wikipatents.com/6280390.html
Inventor(s)Akselrod; Solange (Givat Shmuel, IL); Schechter; Amir (Kfar Saba, IL)
AbstractA system for non-invasively monitoring at least one hemodynamic vascular parameter of an individual is disclosed. The system comprises (a) at least two infrared detectors being positionable in a spaced apart configuration against a region of a skin of the individual above at least one blood vessel, each of said at least two infrared detectors being for individually collecting infrared spectral data from said region of the skin, said infrared spectral data corresponding to a volume of blood present within said at least one blood vessel; and (b) a processing unit being in communication with said at least two infrared detectors, said processing unit being for independently processing said infrared spectral data collected by each of said at least two infrared detectors so as to yield information pertaining to the at least one hemodynamic vascular parameter of the individual.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History Custom Search
Inventor     Akselrod; Solange (Givat Shmuel, IL); Schechter; Amir (Kfar Saba, IL)
Owner/Assignee     Ramot University Authority for Applied Research and Industrial Development (Tel-Aviv, IL)
Patent assignment
All assignments
Company News
Publication Date     August 28, 2001
Application Number     09/473,652
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     December 29, 1999
US Classification     600/485 600/475 600/500
Int'l Classification     A61B 005/00
Examiner     Nasser; Robert L.
Assistant Examiner    
Attorney/Law Firm    
Address
Parent Case    
Priority Data    
USPTO Field of Search     600/485 600/500 600/513 600/504 600/479
Patent Tags     non-invasively monitoring hemodynamic parameters
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing     0%
 Clever     0%
 Complex     0%
 Efficient     0%
 Historic     0%
 Important     0%
 Innovative     100%
 Interesting     0%
 Practical     0%
 Simple     0%
[1 votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
5862805
Nitzan
128/898
Jan,1999

[0 after 0 votes]
5755669
Ono

May,1998

[0 after 0 votes]
5649543
Hosaka
600/493
Jul,1997

[0 after 0 votes]
5617869
Austin

Apr,1997

[0 after 0 votes]
5396895
Takashima
600/500
Mar,1995

[0 after 0 votes]
5237997
Greubel
600/485
Aug,1993

[0 after 0 votes]
5165416
Shinoda
600/485
Nov,1992

[0 after 0 votes]
4960128
Gordon
600/490
Oct,1990

[0 after 0 votes]
4869261
Penaz
600/480
Sep,1989

[0 after 0 votes]
4846189
Sun
600/492
Jul,1989

[0 after 0 votes]
4802488
Eckerle
600/485
Feb,1989

[0 after 0 votes]
4779491
Fujiwara
477/146
Oct,1988

[0 after 0 votes]
4718426
Russell
600/492
Jan,1988

[0 after 0 votes]
4718427
Russell
600/492
Jan,1988

[0 after 0 votes]
4718428
Russell
600/492
Jan,1988

[0 after 0 votes]
4669485
Russell
600/492
Jun,1987

[0 after 0 votes]
4539997
Wesseling
600/480
Sep,1985

[0 after 0 votes]
4524777
Kisioka
600/490
Jun,1985

[0 after 0 votes]
4510940
Wesseling
600/480
Apr,1985

[0 after 0 votes]
4475554
Hyndman
600/473
Oct,1984

[0 after 0 votes]
4423738
Newgard
600/485
Jan,1984

[0 after 0 votes]
4406289
Wesseling
600/483
Sep,1983

[0 after 0 votes]
4269193
Eckerle
600/485
May,1981

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B  50%
$5B - $10B  0%
$2B - $5B  0%
$500M - $2B  50%
$100M - $500M  0%
$10M - $100M  0%
$1M - $10M  0%
$500K - $1M  0%
$100K - $500K  0%
< $100K  0%
[2 votes]
$5,625,000,000
 
$0   $2.5B   $5B   $7.5B   $10B

[0 market size comments]
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%  0%
50% - 74.99%  0%
25% - 49.99%  0%
10 - 24.99%  50%
5 - 9.99%  0%
2 - 4.99%  0%
1 - 1.99%  0%
< 1%  50%
[2 votes]
6.8%
 
0%   25%   50%   75%   100%

[0 market share comments]
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%  0%
50% - 74.99%  0%
25% - 49.99%  0%
10 - 24.99%  0%
5 - 9.99%  100%
2 - 4.99%  0%
1 - 1.99%  0%
< 1%  0%
[1 votes]
7.5%
 
0%   25%   50%   75%   100%

[0 reasonable royalty comments]
Public's "Guesstimation" of Royalty Value
Market Size$5,625,000,000[2 votes]
xMarket Share6.8%[2 votes]
xReasonable Royalty7.5%[1 votes]

$28,476,563

[0 Guesstimation of Royalty Value Comments]
License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 license availability comments]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



  100%

  0%

[1 votes]
[0 owner/assignee comments]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



  100%

  0%

[1 votes]
Most helpful competitive advantage comment
[No comments]

[0 competitive advantage comments]
Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



  100%

  0%

[1 votes]
Most helpful commercial alternative comment
[No comments]

[0 commercial alternatives comments]
 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


What is claimed is:

1. A system for non-invasively monitoring at least one hemodynamic vascular parameter of an individual, the system comprising:

(a) at least two infrared detectors being positionable in a spaced apart configuration against a region of a skin of the individual above at least one blood vessel, each of said at least two infrared detectors being for individually collecting infrared spectral data from said region of the skin, said infrared spectral data corresponding to a volume of blood present within said at least one blood vessel; and

(b) a processing unit being in communication with said at least two infrared detectors, said processing unit being for independently processing said infrared spectral data collected by each of said at least two infrared detectors, said processing unit implementing an algorithm serving to account for blood reflection waves resulting from reflection sites in blood vessels, so as to yield information pertaining to the at least one hemodynamic vascular parameter of the individual.

2. The system of claim 1, wherein each of said at least two infrared detectors detects changes in infrared reflection from said region of said skin.

3. The system of claim 1, wherein each of said at least two infrared detectors includes an infrared source for irradiating said region of said skin and an infrared sensor for sensing infrared reflection reflected from said region of the skin.

4. The system of claim 3, wherein said infrared source irradiates said region with infrared radiation of a wavelength within a range of 800 nm to 960 nm.

5. The system of claim 1, wherein each of said at least two infrared detectors is an infrared photoplethysmograph.

6. The system of claim 1, wherein said at least two infrared detectors include three detectors each independently being for collecting infra red spectral emission data from said region, said three detectors being positionable in a spaced apart configuration against said region of said skin.

7. The system of claim 1, wherein the at least one hemodynamic vascular parameter is selected from the group consisting of blood viscosity, blood density, a radius of said blood vessel, an elasticity of said blood vessel, systolic blood pressure, diastolic blood pressure and continuous blood pressure.

8. The system of claim 1, wherein said infra red spectral data is collected by each of said at least two infrared detectors over the course of at least one heart beat cycle.

9. The system of claim 1, wherein said infra red spectral data is continuously collected by each of said at least two infrared detectors, thus enabling continuous monitoring of the at least one hemodynamic vascular parameter.

10. The system of claim 1, further comprising a device being for obstructing flow in said blood vessel down stream from said region of said skin.

11. The system of claim 1, further comprising an interface communicating with said processing unit, said interface being for providing information pertaining to the at least one hemodynamic vascular parameter to an operator of the system.

12. The system of claim 11, wherein said information pertaining to the at least one hemodynamic vascular parameter is provided to said operator in at least one format selected from the group consisting of a textual format, a graphic format and an audio format.

13. The system of claim 1, wherein said algorithm calculates said information pertaining to the at least one hemodynamic vascular parameter of the individual by determining a wave propagation velocity, a reflection coefficient and a distance to a reflection site.

14. The system of claim 1, wherein said algorithm calculates said information pertaining to the at least one hemodynamic vascular parameter of the individual by extracting values pertaining to displacement of a vessel wall under an assumption that a reflection coefficient is constant with respect to a frequency of a specific harmonic.

15. The system of claim 1, wherein said algorithm calculates said information pertaining to the at least one hemodynamic vascular parameter of the individual taking into account information pertaining to a foot to foot speed and calculating a wall displacement in order to calculate a forward propagating wave.

16. The system of claim 1, wherein said algorithm calculates said information pertaining to the at least one hemodynamic vascular parameter of the individual by extracting values pertaining to wall displacement and blood flow.

17. A method of non-invasively monitoring at least one hemodynamic vascular parameter of an individual, the method comprising:

(a) positioning at least two infrared detectors in a spaced apart configuration against a region of a skin of the individual above at least one blood vessel;

(b) individually collecting in each of said infrared detectors, infrared spectral data from said region of the skin, said infrared spectral data corresponding to a volume of blood present within said at least one blood vessel; and

(b) independently processing said infrared spectral data collected by each of said at least two infrared detectors, while accounting for blood reflection waves resulting from reflection sites in blood vessels, so as to yield information pertaining to the at least one hemodynamic vascular parameter of the individual.

18. The method of claim 17, wherein each of said at least two infrared detectors includes an infrared source for irradiating said region of said skin and an infrared sensor for sensing infrared reflection reflected from said region of the skin.

19. The method of claim 18, wherein said infrared source irradiates said region with infrared radiation of a wavelength within a range of 800 nm to 960 nm.

20. The method of claim 17, wherein each of said at least two infrared detectors is an infrared photoplethysmograph.

21. The method of claim 17, wherein said at least two infrared detectors include three detectors each independently being for collecting infra red spectral emission data from said region, said three detectors being positionable in a spaced apart configuration against said region of said skin.

22. The method of claim 17, wherein said at least one blood vessel includes an artery underlying said region of said skin.

23. The method of claim 17, wherein the at least one hemodynamic vascular parameter is selected from the group consisting of blood viscosity, blood density, a radius of said blood vessel, an elasticity of said blood vessel, systolic blood pressure, diastolic blood pressure and continuous blood pressure.

24. The method of claim 17, wherein said step of individually collecting in each of said infrared detectors, infrared spectral data from said region of the skin, is effected over the course of at least one heart beat cycle.

25. The method of claim 17, wherein said step of individually collecting in each of said infrared detectors, infrared spectral data from said region of the skin, is effected continuously thus enabling continuous monitoring of the at least one hemodynamic vascular parameter.

26. The method of claim 17, further comprising the step of obstructing flow in said blood vessel down stream from said region of said skin prior to said step of collecting in each of said infrared detectors, infrared spectral data from said region of the skin.

27. The method of claim 17, wherein accounting for blood reflection waves resulting from reflection sites in blood vessels is by determining a wave propagation velocity, a reflection coefficient and a distance to a reflection site.

28. The method of claim 17, wherein accounting for blood reflection waves resulting from reflection sites in blood vessels is by extracting values pertaining to motion of a vessel wall under an assumption that a reflection coefficient is constant with respect to a frequency of a specific harmonic.

29. The method of claim 17, wherein accounting for blood reflection waves resulting from reflection sites in blood vessels is by calculations taking into account information pertaining to a foot to foot speed and calculating a wall displacement in order to calculate a forward propagating wave.

30. The method of claim 17, wherein accounting for blood reflection waves resulting from reflection sites in blood vessels is by extracting values pertaining to wall displacement and blood flow.
 Description Submit all comments and votes
 


FIELD AND BACKGROUND OF THE INVENTION

The present invention relates to a system and method for monitoring hemodynamic vascular parameters of a patient and, more particularly, to a system and method utilizing photoplethysmography to monitor parameters associated with, for example, blood pressure and blood flow of a patient.

Hemodynamic vascular parameters such as blood pressure, blood flow and the like which are typically measured using non-invasive procedures are routinely monitored by physicians in order to determine the physiological state of the heart and circulatory system of a patient. Of these hemodynamic vascular parameters, blood pressure is the most commonly monitored.

Blood pressure is the force within the circulatory system of an individual that ensures a flow of blood and delivery of oxygen and nutrients to the tissue.

Abnormal blood pressure readings and/or blood pressure fluctuations over time are oftentimes indicative of heart or circulatory disorders. Hypertension is one of the most common diseases in the adult population, often accompanied by secondary cardiovascular damage. In addition, prolonged reduction or loss of pressure severely limits the amount of tissue perfusion and could therefore result in damage to, or even death of, the tissue. Although some tissues can tolerate hypoperfusion for fairly long periods of time, the brain, heart and kidneys are very sensitive to a reduction in blood flow. Thus, blood pressure is a frequently monitored both routinely and also during surgical procedures where ample supply of blood to tissues is crucial for tissue survival.

During and after surgery, blood pressure is affected by the type of surgery and physiological factors such as the body's response to the surgery. Moreover, during and after surgery, blood pressure is manipulated and controlled using various medications. Often, these physiological factors and the given medications result in a situation requiring immediate blood pressure measurement, and corrective action.

In some clinical situations, dramatic changes in blood pressure can occur instantaneously. For example, a sudden change in pressure may occur due to a reaction to drug therapy. Also, patient reactions to the surgery, sudden occlusion of an artery due to an embolism, or even sudden cardiac arrest are a few of the possibilities. It is very important to detect these sudden changes immediately, and to insure that the direction and amount of the changes be accurate within certain limits. Conversely, it is equally important that false indications of significant blood pressure changes do not occur.

Due to the above described reasons, constant monitoring of blood pressure of a patient is often necessary. The traditional method of measuring blood pressure is with the use of a occlusive cuff, a stethoscope and a pressure manometer. However, this technique is slow, subjective in nature, requires the intervention of a skilled clinician and does not provide the timely readings frequently required in critical situations.

For these reasons, two methods of measuring blood pressure have been developed: invasive, continuous (beat-to-beat) measurements and noninvasive, intermittent methods that use an automated occlusive cuff device.

Invasive methods suffer from several inherent limitations including the risk of embolization, nerve damage, infection, bleeding and vessel wall damage. In addition due to their invasive nature such methods are more suitable to blood pressure monitoring during surgical procedures.

The noninvasive cuff method does not have the inherent disadvantages of the invasive technique, however it also does not provide the continuous beat-to-beat pressure variations obtainable with the invasive method. Further, the noninvasive cuff method typically requires 15 to 45 seconds to obtain a measurement, and since it is an occlusive technique, the method should allow a minimum of 15 seconds to ensure sufficient venous recovery. Thus, at best there is typically 1/2 to 1 minute between updated pressure measurements. When fast acting medications are administered, this is an inordinately long amount of time to wait for an updated pressure reading. Also, frequent cuff inflation over extended periods of time may result in ecchymosis and/or nerve damage in the area underlying the cuff.

Several systems have been developed to address the need for continuous, noninvasive blood pressure measurement.

European Patent Document 0048060 and U.S. Pat. Nos. 4,406,289, 4,510,940 and 4,539,997 to Wesseling et al., U.S. Pat. No. 4,475,554 to Hyndman, U.S. Pat. No. 4,524,777 (1985) to Kisioka, U.S. Pat. No. 4,846,189 to Sun and U.S. Pat. No. 4,869,261 to Penaz, all relate to methods and devices utilizing a technique known as photoplethysmography which is commercially implemented in a device known as the FINAPRES system (Omeda).

The FINAPRES system uses a small inflatable air cuff containing an infrared photoplethysmograph. The cuff is applied to one of the subject's fingers or thumb, and the photoplethysmograph measures the absorption at a wavelength specific for hemoglobin. The device first measures the individual's mean arterial pressure, and then varies the cuff pressure around the finger to maintain the transmural pressure at zero as determined by the photoplethysmograph. The device tracks the intra-arterial pressure wave by adjusting the cuff pressure to maintain the optical absorption constant at all times.

There are several major disadvantages to this technique. The signal amplitude detected by the photoplethysmograph is a function of the changes in the diameter of the artery within the finger, and is determined by the compliance characteristics of the artery. The device maintains this amplitude at a constant value. This value, or set point, must correspond to the point of zero transmural stress in order to determine the correct pressure. During surgery for example, the device cannot differentiate between changes in photoplethysmograph amplitude due to intra-arterial pressure changes and those due to arterial wall compliance changes. Consequently, the FINAPRES system cannot accurately respond to pressure changes caused by changes in vasomotor tone. In addition, maintaining continuous cuff pressure causes restriction of the circulation in the finger being used, which is uncomfortable when maintained for extended periods of time such as during surgery or during a stay in an intensive care unit.

U.S. Pat. Nos. 4,669,485, 4,718,426, 4,718,427 and 4,718,428 all to Russel, describe a device using a conventional blood pressure cuff applied to a person's upper arm to sense an oscillometric signal. The subject's blood pressure is obtained initially by the oscillometric technique, and then changes in the oscillometric signal indicate changes from this initial reference pressure.

There are two inherent limitations to this device. First, the use of a large air bag as the sensing device provides a means for detecting the fundamental and lower harmonics of the blood pressure signal (up to a few Hertz), but also acts to attenuate many higher order harmonics containing key information relating to blood pressure variations. Second, the use of a cuff to detect the oscillometric signal creates a signal that is very sensitive to patient movement. Since patient movement is often encountered during surgery or in critical care situations, the device requires frequent recalibration to be accurate.

U.S. Pat. Nos. 4,269,193, 4,799,491 and 4,802,488 to Eckerle, U.S. Pat. No. 4,423,738 to Newgard, and U.S. Pat. No. 5,165,416 to Shinoda et al., all describe methods and devices for detecting the pressure wave in the underlying artery of an individual using a technique known as the tonometric technique.

These device and methods utilize a multi-element piezoresistive detector to noninvasively detect the blood pressure wave at the radial artery. This signal is then processed and changes in its amplitude are used to interpret changes to the pressure values obtained using the conventional oscillometric technique.

A major drawback to this technique lies in the method of interpreting changes to the waveform signal. Reliance solely on amplitude changes is misleading since the signal amplitude may increase or decrease with an increase in blood pressure, etc. Secondly, it is dependent on the artery being exactly flat, and variations in artery flatness can introduce errors. It also assumes that the selected sensing element is small with respect to the artery, and that it does not move from its position centered over the artery. Thus, any movement such as that often encountered in surgery or critical care situations will reduce the accuracy of this device.

European Patent Document 0 443 267 A 1 to Smith, describes a technique for monitoring changes in pulse transit time to provide a continuous, noninvasive measure of blood pressure. This technique was developed by Sentinel Monitoring, Inc., of Indianapolis, Ind., and uses a duplicity of photometric detectors similar to those used with oximeters. Typically, one detector is applied to the subject's ear lobe, and the other to a finger. The detectors are used for determining changes in the arrival time of the pulse at each of these sites, and to determine changes in local blood volume. Following an initial calibration pressure measurement obtained with a conventional blood pressure cuff, the Smith device adjusts these pressures by interpreting changes in the pulse transit time and in the optical density of the photoplethysmograph signal.

There are two disadvantages to the Smith technique. First, changes in pulse transit time are very small along major arteries. As a result, small errors caused by patient movement or noise render questionable data. Second, small variations in photoplethysmographic waveform morphology or detector noise can generate measurement errors greater than the sensitivity of the technique to changes in blood pressure.

U.S. Pat. No. 4,960,128 to Gordon, et al., describes a method of determining blood pressure by measuring a single harmonic of the frequencies and displacements of the patient's arterial wall. In Gordon, initial (absolute) blood pressure values arc obtained with a cuff and stethoscope or via an intermittent automated cuff machine, and manually entered into the device as initial reference values. A continuous detector signal is supplied by a noninvasive detector attached to the patient's skin above an artery. The detector signal is filtered, amplified and then sampled. This time sampled detector data is then Fourier transformed into the frequency domain and normalized.

As blood pressure changes, the reported frequencies and their relative amplitudes change. A comparison is made between the fundamental frequency of the present signal and the initial signal. For each shift in frequency (+or -) of 1 Hz, the offset is adjusted correspondingly to yield a change of 5 mm Hg. Thus, Gordon shows a device in which the patient's blood pressure is determined based on the difference in position of the fundamental frequency of the detector signal and initial signal.

The technique described by Gordon does not adequately account for the plurality of factors that can reflect a change in blood pressure. There is a multitude of waveshapes that can accompany a given set of blood pressure values, and the Gordon technique is limited by its function of comparing the frequency with the maximum amplitude of the current signal to that of the initial signal to determine blood pressure.

There is thus a widely recognized need for, and it would be highly advantageous to have, a system and method for accurately and noninvasively monitoring continuous beat-to-beat blood pressure and other important hemodynamic vascular parameters of a patient which is devoid of the above limitations.

SUMMARY OF THE INVENTION

According to one aspect of the present invention there is provided a system for non-invasively monitoring at least one hemodynamic vascular parameter of an individual, the system comprising (a) at least two infrared detectors being positionable in a spaced apart configuration against a region of a skin of the individual above at least one blood vessel, each of said at least two infrared detectors being for individually collecting infrared spectral data from said region of the skin, said infrared spectral data